Table 1 The characteristics of included studies for meta-analysis

Grimm MO al.

2002 [25]

82

RP

50

53%(5-y)

36%(10-y)

90%(5-y)

47%(10-y)

86%(5-y)

34%(10-y)

ADP

32

31%(5-y)10

15%(10-y)

53%(5-y)

32%(10-y)

39%(5-y)

17%10-y)

Thomas Steuber al.

2011 [26]

158

RP-

50

62(49-70)

98(88-113)

61%(5-y)

31%(10-y)

81%(5-y)

46%(10-y)

80%(5-y)

42%(10-y)

RP+

108

64(46-76)

98(88-113)

77%(5-y)

61%(10-y)

84%(5-y)

76%(10-y)

79%(5-y)

69%(10-y)

Axel Heidenreich al.

2015 [27]

61

ADT

38

63.9(47-83)

44.0 (24-96)

84.2%(3-y)

78.9%(3-y)

CRP

23

61(42-69)

40.6 (3-71)

95.6%(3-y)

91.3%(3-y)

Bimal Bhindi al.

2017 [28]

RRP

34

79%(5-y)

77%

-RRP

34

55%(5-y)

55%

M Moschini al.

2016 [29]

61

Surgery

31

62 (56–66)

38.8

100%(1-y)

91.3%(3-y)

61.9%(5-y)

ADT

16

59 (54–59)

93.8%(1-y)

76.9%(3-y)

46.2%(5-y)

Ming-Xiong Sheng al

2017 [30]

49

Surgery

23

68.1 ± 9.9 (57–83)

37(19-53)

86.96(5-y)

86.96%(5-y)

ADT

26

72.0 ± 4.7 (63–84)

41(24-56)

92.31%(5-y)

73.08%(5-y)

Won Sik Jang al.

2018 [31]

79

ADT

41

71 (67−76)

40(25-48)

41/41(1-y)

17/41(3-y)

4/41(5-y)

40/41(1-y)

16/41(3-y)

6/41(5-y)

RARP

38

65 (62−69)

40(25-48)

37/38(1-y)

24/38(3-y)

14/38(5-y)

38/38(1-y)

31/38(3-y)

14/38(5-y)

Tian Lan al.

2019 [32]

111

ADT

76

71.17 ±7.73

35(22-41)

27.0%(3years)

21.0%(5years)

87.9%(3years)

74.9%(5years)

85.5%(3-y)

CRP+ADT

35

67.83± 7.19

35(25-45)

42.7%(3years)

19.0%(5years)

90.8%(3years)

63.6%(5years)

88.6%(3-y)

Nasser Simforoosh al.

2019 [33]

49

ST

23

22.8(14-43)

65.2%(3-y)

65.2%(3-y)

CRP

26

19.2(9-42)

76.9%(3-y)

76.9%(3-y)

Shubin Si al.

2021 [34]

84

RP

27

76.67 ± 9.66

96.2%(3-y)

76.0%(5-y)

-RP

57

76.42 ± 9.69

94.7%(3-y)

74.9%(5-y)